Printability of contact-hole patterns in EUVL using 0.3-NA HiNA optics
暂无分享,去创建一个
[1] Robert Socha,et al. Near-0.3 k1 full pitch range contact hole patterning using chromeless phase lithography (CPL) , 2003, SPIE Photomask Technology.
[2] Hatsuyuki Tanaka,et al. Advanced microlithography process with chemical shrink technology , 2000, Advanced Lithography.
[3] Han-Ku Cho,et al. Strategy for sub-80-nm contact hole patterning considering device fabrication , 2004, SPIE Advanced Lithography.
[4] Yuusuke Tanaka,et al. Evaluation of pattern fidelity in EUVL using a high-numerical-aperture small-field EUV exposure tool (HiNA) , 2005, SPIE Advanced Lithography.
[5] Yuusuke Tanaka,et al. EUV absorbance and dry-etching characteristics of TaGeN films for EUVL mask absorber , 2004, SPIE Advanced Lithography.
[6] Iwao Nishiyama,et al. Lithographic performance of high-numerical-aperture (NA=0.3) EUV small-field exposure tool (HINA) , 2005, SPIE Advanced Lithography.
[7] Y. Matsui,et al. 0.1 /spl mu/m level contact hole pattern formation with KrF lithography by resolution enhancement lithography assisted by chemical shrink (RELACS) , 1998, International Electron Devices Meeting 1998. Technical Digest (Cat. No.98CH36217).
[8] Vivek Singh,et al. Lithography strategy for 65-nm node , 2002, Photomask Japan.
[9] Yuusuke Tanaka,et al. Study of mask process development for EUVL , 2004, Photomask Japan.
[10] Iwao Nishiyama,et al. Development of projection optics set-3 for high-numerical-aperture extreme ultraviolet exposure tool (HiNA) , 2004 .
[11] Y. Iba,et al. Amorphous Refractory Compound Film Material for X-Ray Mask Absorbers , 2000 .
[12] Hiroaki Oizumi,et al. Fabrication of aspherical mirrors for HiNA (high numerical aperture EUV exposure tool) set-3 projection optics , 2004, SPIE Advanced Lithography.
[13] Nakajima Masayuki,et al. NTT superconducting storage ring—Super‐ALIS , 1989 .
[14] Kazuya Ota,et al. Development of illumination optics and projection optics for high-NA EUV exposure tool (HiNA) , 2003, SPIE Advanced Lithography.